LATIN AMERICA MALE INFERTILITY MARKET 2023-2030

Triton’s research report infers that the male infertility market in Latin America is predicted to display a compound annual growth rate of 5.36% in revenue over the forecasting period 2023-2030.

Report scope can be customized per your requirements - Request Free Sample Report

The countries evaluated in the region are:

• Brazil

• Mexico

• Rest of Latin America

In Latin America, the male infertility market expansion is fueled by the increasing infertility rate among males caused by sedentary lifestyles, substance abuse, hormonal imbalances, and other factors. Additionally, the prevalence of diseases like cancer and diabetes contributes to male infertility. Other than this, the growth of medical and fertility tourism widens the scope and growth of the studied market to a large extent.

Brazil dominates the market with the largest market share. The sedentary lifestyles, hormonal imbalances, prostate cancer, and diabetes have increased the male infertility rate, resulting in a rising need for advanced treatments. For instance, diabetes is a significant concern in Brazil, affecting roughly 15.7 million adults, representing about 10.5% of the population, as per the IDF Diabetes Atlas 2021. This high prevalence of diseases is likely to negatively impact male fertility, thereby influencing the male infertility market’s development.

Furthermore, the nation boasts approximately 150 centers accredited by the Joint Commission International (JCI) that offer a wide range of medical services. The nation has emerged as a hub for medical tourism due to low costs, high success rates, and robust licensing standards. These factors are expected to fuel treatment options, thereby widening the scope of the male infertility market.

Various medications that effectively treat male infertility are available, including hormone replacement therapy and male fertility injections, that improve sperm morphology and motility. The approved medications for managing male factor infertility are gonadotropins, hormones produced by the anterior pituitary. These hormones stimulate the testes, leading to increased sex hormone synthesis and enhanced sperm production.

The market is broadly bifurcated into treatment and test type, with treatment further comprising medications and assisted reproductive technology and surgery.

EMD Serono Inc, Halotech DNA, Endo International Plc, Bayer AG, and Vitrolife are some of the prominent companies in the market.

Halotech DNA is a biotechnology company specializing in fertility solutions. The company’s focus lies in infertility research, along with the production and distribution of in vitro diagnostic kits and accessories. Its primary goal is to support dedicated assisted reproduction technology clinics, enhancing their success rates while providing customers with high-quality information and complementary assessment reports. Halotech DNA has established partnerships for product commercialization in over 50 countries worldwide, including across Latin America.

Key deliverables of the report:

● Market CAGR during the forecasting years 2023-2030

● Detailed data highlighting key insights, industry components, and market strategies

● Comprehensive information and estimation of the male infertility market revenue growth in Latin America and its influence on the parent market

● In-depth study of forthcoming trends in consumer behavioral patterns

● A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces

● A wide-ranging study of factors that will challenge the LA male infertility market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.

Major Players in the Market

Related Reports

Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT

Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2022-2028

Market by Therapeutics, Diagno ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA MALE INFERTILITY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. PARENT MARKET ANALYSIS

2.2. IMPACT ANALYSIS ON THE MALE INFERTILITY MARKET

2.2.1. COVID-19 IMPACT

2.2.2. UKRAINE-RUSSIA WAR IMPACT

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET MATURITY ANALYSIS

2.5. KEY MARKET STRATEGIES

2.5.1. COLLABORATIONS

2.5.2. PRODUCT LAUNCHES

2.5.3. MERGERS & ACQUISITIONS

2.5.4. BUSINESS DIVESTITURES & EXPANSIONS

2.6. MARKET DRIVERS

2.6.1. PREVALENCE OF INFERTILITY

2.6.2. USE OF ASSISTED REPRODUCTIVE TECHNOLOGIES

2.6.3. TECHNOLOGICAL INNOVATIONS AND ADVANCEMENTS

2.7. MARKET CHALLENGE

2.7.1. HIGH COST OF TREATMENT

2.8. MARKET OPPORTUNITIES

2.8.1. INCREASING ACCEPTANCE OF MINIMALLY INVASIVE SURGERIES

2.8.2. GROWING AVAILABILITY OF INFERTILITY TREATMENT DRUGS, PROCEDURES, AND DEVICES

2.8.3. GOVERNMENT INITIATIVES TOWARD IMPROVING REIMBURSEMENT POLICIES

2.9. ANALYST PERSPECTIVE

3. LATIN AMERICA MALE INFERTILITY MARKET – BY TEST TYPE

3.1. DNA FRAGMENTATION TECHNIQUE

3.2. OXIDATIVE STRESS ANALYSIS

3.3. MICROSCOPIC EXAMINATION

3.4. SPERM AGGLUTINATION

3.5. COMPUTER-ASSISTED SEMEN ANALYSIS

3.6. SPERM PENETRATION ASSAY

3.7. OTHER TEST TYPES

4. LATIN AMERICA MALE INFERTILITY MARKET – BY TREATMENT

4.1. ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY

4.2. MEDICATIONS

5. LATIN AMERICA MALE INFERTILITY MARKET – BY COUNTRY OUTLOOK

5.1. COUNTRY ANALYSIS

5.1.1. BRAZIL

5.1.1.1. BRAZIL MALE INFERTILITY MARKET FORECAST & PROSPECTS

5.1.2. MEXICO

5.1.2.1. MEXICO MALE INFERTILITY MARKET FORECAST & PROSPECTS

5.1.3. REST OF LATIN AMERICA

5.1.3.1. REST OF LATIN AMERICA MALE INFERTILITY MARKET FORECAST & PROSPECTS

6. COMPETITIVE LANDSCAPE

6.1. HALOTECH DNA

6.1.1. OVERVIEW

6.1.2. PRODUCT PORTFOLIO

6.2. EMD SERONO INC

6.2.1. OVERVIEW

6.2.2. PRODUCT PORTFOLIO

6.2.3. KEY STRENGTHS

6.2.4. KEY CHALLENGES

6.3. ENDO INTERNATIONAL PLC

6.3.1. OVERVIEW

6.3.2. PRODUCT PORTFOLIO

6.3.3. KEY STRENGTHS

6.3.4. KEY CHALLENGES

6.4. VITROLIFE

6.4.1. OVERVIEW

6.4.2. PRODUCT PORTFOLIO

6.4.3. KEY STRENGTHS

6.4.4. KEY CHALLENGES

6.5. BAYER AG

6.5.1. OVERVIEW

6.5.2. PRODUCT PORTFOLIO

6.5.3. KEY STRENGTHS

6.5.4. KEY CHALLENGES

6.6. AYTU BIOPHARMA

6.6.1. OVERVIEW

6.6.2. PRODUCT PORTFOLIO

6.6.3. KEY STRENGTHS

6.6.4. KEY CHALLENGES

6.7. ZYDUS LIFESCIENCES LIMITED

6.7.1. OVERVIEW

6.7.2. PRODUCT PORTFOLIO

6.7.3. KEY STRENGTHS

6.7.4. KEY CHALLENGES

6.8. CINNAGEN CO

6.8.1. OVERVIEW

6.8.2. PRODUCT PORTFOLIO

6.8.3. KEY STRENGTHS

6.8.4. KEY CHALLENGES

6.9. SANOFI SA

6.9.1. OVERVIEW

6.9.2. PRODUCT PORTFOLIO

6.9.3. KEY STRENGTHS

6.9.4. KEY CHALLENGES

6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS

6.10.1. OVERVIEW

6.10.2. PRODUCT PORTFOLIO

6.10.3. KEY STRENGTHS

6.10.4. KEY CHALLENGES

7. RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: LATIN AMERICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

TABLE 2: LIST OF COLLABORATIONS

TABLE 3: LIST OF PRODUCT LAUNCHES

TABLE 4: LIST OF MERGERS & ACQUISITIONS

TABLE 5: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 6: LATIN AMERICA MALE INFERTILITY MARKET, BY TEST TYPE, 2023-2030 (IN $ MILLION)

TABLE 7: LATIN AMERICA MALE INFERTILITY MARKET, BY TREATMENT, 2023-2030 (IN $ MILLION)

TABLE 8: LATIN AMERICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET MATURITY ANALYSIS

FIGURE 2: LATIN AMERICA MALE INFERTILITY MARKET, BY TYPE, 2022 & 2030 (IN %)

FIGURE 3: LATIN AMERICA MALE INFERTILITY MARKET, BY DNA FRAGMENTATION TECHNIQUE, 2023-2030 (IN $ MILLION)

FIGURE 4: LATIN AMERICA MALE INFERTILITY MARKET, BY OXIDATIVE STRESS ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 5: LATIN AMERICA MALE INFERTILITY MARKET, BY MICROSCOPIC EXAMINATION, 2023-2030 (IN $ MILLION)

FIGURE 6: LATIN AMERICA MALE INFERTILITY MARKET, BY SPERM AGGLUTINATION, 2023-2030 (IN $ MILLION)

FIGURE 7: LATIN AMERICA MALE INFERTILITY MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS, 2023-2030 (IN $ MILLION)

FIGURE 8: LATIN AMERICA MALE INFERTILITY MARKET, BY SPERM PENETRATION ASSAY, 2023-2030 (IN $ MILLION)

FIGURE 9: LATIN AMERICA MALE INFERTILITY MARKET, BY OTHER TEST TYPES, 2023-2030 (IN $ MILLION)

FIGURE 10: LATIN AMERICA MALE INFERTILITY MARKET, BY TREATMENT, 2022 & 2030 (IN %)

FIGURE 11: LATIN AMERICA MALE INFERTILITY MARKET, BY ASSISTED REPRODUCTIVE TECHNOLOGY AND SURGERY, 2023-2030 (IN $ MILLION)

FIGURE 12: LATIN AMERICA MALE INFERTILITY MARKET, BY MEDICATIONS, 2023-2030 (IN $ MILLION)

FIGURE 13: LATIN AMERICA MALE INFERTILITY MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)

FIGURE 14: BRAZIL MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)

FIGURE 15: MEXICO MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)

FIGURE 16: REST OF LATIN AMERICA MALE INFERTILITY MARKET 2023-2030 (IN $ MILLION)